{"title":"类风湿关节炎药物审批试验应主要采用哪种 ACR 反应定义?","authors":"V. Konzett, A. Kerschbaumer","doi":"10.1007/s12688-024-00720-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74732,"journal":{"name":"Rheuma plus","volume":" 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Which ACR Response Definition Should Primarily be used for Drug Approval Trials in Rheumatoid Arthritis?\",\"authors\":\"V. Konzett, A. Kerschbaumer\",\"doi\":\"10.1007/s12688-024-00720-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74732,\"journal\":{\"name\":\"Rheuma plus\",\"volume\":\" 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rheuma plus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12688-024-00720-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheuma plus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12688-024-00720-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}